Skip to main content
. 2020 Apr 4;9(4):161. doi: 10.3390/antibiotics9040161

Table 2.

Virulence factor (VF)-encoding genes observed from the 196 isolates and the isolates included in the 10 most frequent sequence types.

VF Gene Number (%) of Isolates
Total
(n = 196)
B2
ST131
(n = 23)
A
ST10
(n = 9)
B2
ST12
(n = 8)
B1
ST58
(n = 5)
D
ST69
(n = 13)
B2
ST73
(n = 21)
C
ST88
(n = 12)
B2
ST95
(n = 10)
B2
ST127
(n = 7)
B2
ST141
(n = 14)
Adhesins
fimH 193 (98.5) 23 9 8 5 13 21 12 10 7 14
fimAvMT78 27 (13.8) 0 4 0 0 0 0 0 4 0 0
papAH 84 (42.9) 6 1 8 0 6 18 10 7 6 7
papC 87 (44.4) 6 1 8 0 7 18 10 7 6 7
papEF 92 (46.9) 6 1 8 0 11 18 10 7 6 7
sfa/focDE 58 (29.6) 1 0 8 0 0 20 0 2 5 13
afa/draBC 11(5.6) 7 2 0 0 0 0 0 0 0 0
yfcV 106 (54.1) 20 0 8 0 0 21 0 10 7 14
Toxins
sat 47 (24.0) 13 3 0 0 9 12 0 0 0 0
cnf1 49 (25.0) 4 0 8 0 0 17 0 0 7 7
hlyA 55 (28.1) 3 1 8 0 0 20 0 0 7 7
hlyF 44 (22.4) 2 2 0 4 0 0 8 7 0 3
cdtB 12 (6.1) 3 0 0 0 0 6 0 2 0 0
tsh 7 (3.6) 0 0 0 0 0 0 0 2 0 1
vat 80 (40.8) 0 0 7 0 0 20 0 10 7 14
Iron uptake
iucD 99 (50.5) 16 6 2 4 11 12 8 7 0 3
iutA 99 (50.5) 16 6 2 4 11 12 8 7 0 3
iroN 93 (47.4) 3 2 8 4 0 20 8 6 4 14
fyuA 162 (82.7) 23 7 8 4 12 21 10 10 7 14
chuA 135 (68.9) 23 0 8 0 12 21 0 10 7 14
Capsule
kpsM II 119 (60.7) 17 2 4 0 10 20 0 10 7 14
neuC-K1 35 (17.9) 0 0 0 0 0 0 0 10 1 12
kpsM II-K2 17 (8.7) 7 0 0 0 3 0 0 0 0 0
kpsM II-K5 67 (34.2) 10 2 4 0 7 20 0 0 6 2
kpsM III 6 (3.1) 0 0 3 0 1 0 0 0 0 0
Miscellaneous
cvaC 35 (17.9) 2 2 0 4 0 0 7 7 0 3
iss 46 (23.5) 2 2 1 4 0 2 8 5 0 5
traT 111 (56.6) 17 4 6 5 7 4 9 8 3 6
ibeA 23 (11.7) 4 0 0 0 0 0 0 4 0 3
malX 109 (55.6) 21 0 8 0 0 21 0 10 7 14
usp 107 (54.6) 23 0 8 0 0 21 0 10 7 14
ompT 151 (77.0) 23 2 8 4 12 21 10 10 7 14
ExPEC status 121 (61.7) 15 2 8 0 9 21 6 10 7 14
UPEC status 106 (54.1) 20 0 8 0 0 21 0 10 7 14
Range of VFs 1 to 23 8 to 20 1 to 14 16-19 2-10 5-12 13-20 6-13 13-22 13-17 12-23
Mean of VFs 11.6 12.3 6.3 17.1 8.4 9.4 17.4 9.8 18.2 15.4 16.2

Bold indicates the VF-encoding gene present in ≥60% of the isolates.